- Home
- KNSA vs TY Comparison
KNSA vs TY Comparison
Compare KNSA & TY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- TY
- Stock Information
- Founded
- KNSA 2015
- TY 1929
- Country
- KNSA United Kingdom
- TY United States
- Employees
- KNSA N/A
- TY N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- TY Finance Companies
- Sector
- KNSA Health Care
- TY Finance
- Exchange
- KNSA Nasdaq
- TY Nasdaq
- Market Cap
- KNSA 1.9B
- TY 1.6B
- IPO Year
- KNSA 2018
- TY N/A
- Fundamental
- Price
- KNSA $27.36
- TY $31.18
- Analyst Decision
- KNSA Strong Buy
- TY
- Analyst Count
- KNSA 5
- TY 0
- Target Price
- KNSA $38.80
- TY N/A
- AVG Volume (30 Days)
- KNSA 474.9K
- TY 43.0K
- Earning Date
- KNSA 07-22-2025
- TY 01-01-0001
- Dividend Yield
- KNSA N/A
- TY 3.36%
- EPS Growth
- KNSA N/A
- TY N/A
- EPS
- KNSA N/A
- TY 4.78
- Revenue
- KNSA $481,166,000.00
- TY N/A
- Revenue This Year
- KNSA $37.21
- TY N/A
- Revenue Next Year
- KNSA $5.32
- TY N/A
- P/E Ratio
- KNSA N/A
- TY $6.38
- Revenue Growth
- KNSA 59.45
- TY N/A
- 52 Week Low
- KNSA $17.38
- TY $25.16
- 52 Week High
- KNSA $28.56
- TY $30.73
- Technical
- Relative Strength Index (RSI)
- KNSA 62.48
- TY 60.86
- Support Level
- KNSA $26.28
- TY $30.92
- Resistance Level
- KNSA $27.90
- TY $31.79
- Average True Range (ATR)
- KNSA 0.99
- TY 0.45
- MACD
- KNSA -0.07
- TY -0.01
- Stochastic Oscillator
- KNSA 82.30
- TY 47.44
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About TY Tri Continental Corporation
Tri-Continental Corp is a United States-based closed-end management investment company. It invests to produce future growth of both capital and income while providing reasonable current income. The fund is divided into two equal segments namely, the equity segment uses quantitative models to select individual stocks whereas the Flexible capital income segment invests across a company's investable capital structure, including stocks, bonds, and convertible securities. The Fund invests in a range of sectors, which include consumer discretionary, consumer staples, energy, financials, healthcare, industrials, information technology, industrials, materials, real estate, telecommunication services, utilities, aerospace and defense, banking, chemicals, and others.